ILC

BostonGene and Collaborators Honored with GRASP Advocate Choice Award at the 2024 ASCO Annual Meeting

Retrieved on: 
星期二, 六月 11, 2024

BostonGene , a leading provider of AI-driven molecular and immune profiling solutions, today announced the presentation of its poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting has received the GRASP Advocate Choice Award.

Key Points: 
  • BostonGene , a leading provider of AI-driven molecular and immune profiling solutions, today announced the presentation of its poster at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting has received the GRASP Advocate Choice Award.
  • Founded in 2019 by two breast cancer survivors and advocates, GRASP aims to break down silos and foster connections within the cancer community.
  • The 2024 GRASP event will be held in conjunction with the ASCO Annual Meeting on June 12-13, 2024.
  • "Our collaborative efforts in TME profiling are vital in unraveling the complexities of ILC and tailoring personalized treatments for patients."

Ingersoll Rand Closes on ILC Dover and Announces Acquisition of Three Additional Companies

Retrieved on: 
星期一, 六月 3, 2024

The acquisition will complement Ingersoll Rand’s portfolio of mission critical, high margin pumping solutions across life science, food and beverage, medical, natural gas, and wastewater treatment industries.

Key Points: 
  • The acquisition will complement Ingersoll Rand’s portfolio of mission critical, high margin pumping solutions across life science, food and beverage, medical, natural gas, and wastewater treatment industries.
  • The acquisition is expected to expand the CAPS portfolio to include additional Ingersoll Rand products, which will provide greater expertise and choice for customers.
  • “I remain energized by Ingersoll Rand’s growth trajectory,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand.
  • “These acquisitions demonstrate our continued commitment to our inorganic growth strategy and ability to execute on our acquisition pipeline.”

National Academy of Sports Medicine® (NASM) and HOSA Partner to Promote New Pathways in Fitness and Wellness for Students Around the World

Retrieved on: 
星期三, 五月 29, 2024

HOSA’s mission is to empower future health professionals to become leaders in the global health community through education, collaboration, and experience.

Key Points: 
  • HOSA’s mission is to empower future health professionals to become leaders in the global health community through education, collaboration, and experience.
  • The purpose of this partnership is to integrate NASM’s esteemed fitness and wellness programs with HOSA’s expansive network of aspiring health professionals.
  • "Together, we can make a positive impact on the wellbeing of our communities by fostering the next generation of fitness and wellness professionals."
  • “This partnership will enhance the development of future fitness and wellness professionals by ensuring student pathways are enriched with relevant learning, career awareness, and accomplishments.”

BostonGene Announces Seven Abstract Acceptances at the 2024 American Society of Clinical Oncology Annual Meeting

Retrieved on: 
星期三, 五月 29, 2024

These findings highlight the importance of RNA-seq to advance research and identify potential biomarkers for sarcomas.

Key Points: 
  • These findings highlight the importance of RNA-seq to advance research and identify potential biomarkers for sarcomas.
  • In this study, single-cell RNA-seq was used to investigate the connection between breast cancer classification and luminal expression profiles.
  • Research conducted in collaboration with City of Hope Comprehensive Cancer Center, Sarcoma Oncology Center, Duke University and Expression Therapeutics
    For more information, please visit the 2024 ASCO Annual Meeting website .
  • The abstracts will be published online in the Journal of Clinical Oncology supplement for the ASCO Annual Meeting Proceedings.

ClearB Therapeutics Announces Upcoming Poster Presentations of Pre-Clinical Chronic Hepatitis B Data at EASL 2024

Retrieved on: 
星期三, 五月 29, 2024

In addition, one of the posters has been selected as a TOP presentation (see details below).

Key Points: 
  • In addition, one of the posters has been selected as a TOP presentation (see details below).
  • “While we are progressing our therapeutic vaccine candidate, CLB-3000, in first in human trials, we are excited to share preclinical data on other approaches we are pursuing with the Hepatitis B community,” said Aileen Rubio, PhD, CEO of ClearB Therapeutics.
  • “Chronic Hepatitis B (CHB) infection remains a substantial global health care problem in need of effective antiviral and immunomodulatory therapies.
  • We believe that ClearB’s therapeutic vaccine and our other approaches could become an important component of combination treatment regimens.”
    For more information regarding the abstracts at EASL 2024 please visit:

International Lithium Completes Purchase of the Highly Prospective Firesteel Copper Project Near Upsala, Ontario and Application for Drilling Permits

Retrieved on: 
星期二, 五月 21, 2024

At the same time the Company announces that it has filed applications for permits to conduct the first drilling program at Firesteel targeting copper mineralization within the 6,600 hectare property.

Key Points: 
  • At the same time the Company announces that it has filed applications for permits to conduct the first drilling program at Firesteel targeting copper mineralization within the 6,600 hectare property.
  • Initial studies reveal highly prospective amounts of copper at Firesteel, and there is also a smaller amount of cobalt and some gold there too."
  • Figure 1: Location of the Firesteel Copper-Cobalt project relative to Thunder Bay, the Raleigh Lake Lithium-Rubidium deposits and the Wolf Ridge project area.
  • To view an enhanced version of this graphic, please visit:
    Figure 2: Firesteel Copper-Cobalt project claims outline and local infrastructure.

Ingersoll Rand to Acquire ILC Dover to Expand Presence in Life Sciences

Retrieved on: 
星期一, 三月 25, 2024

In connection with this acquisition, Ingersoll Rand will establish a life sciences platform within its P&ST segment, consisting of ILC plus Ingersoll Rand’s life science-focused brands including Thomas, Welch, Zinsser Analytic, Tricontinent, Air Dimensions, and ILS.

Key Points: 
  • In connection with this acquisition, Ingersoll Rand will establish a life sciences platform within its P&ST segment, consisting of ILC plus Ingersoll Rand’s life science-focused brands including Thomas, Welch, Zinsser Analytic, Tricontinent, Air Dimensions, and ILS.
  • Corey Walker, ILC President and CEO, will lead the life sciences platform and join the Ingersoll Rand leadership team, reporting to Vicente Reynal, chairman and chief executive officer.
  • “This acquisition is the next phase of our long-term vision to expand into higher-growth end markets like life sciences.
  • We see a strong fit between Ingersoll Rand and ILC, and we are confident that Ingersoll Rand is the right partner for its next stage of growth.”
    This acquisition is immediately accretive to Ingersoll Rand’s growth and margin rates.

Express' Standout Year Steals the Spotlight at Annual Conference in Denver, Colorado

Retrieved on: 
星期二, 三月 12, 2024

When West was 16, circumstances beyond his control left him homeless and living out of his car.

Key Points: 
  • When West was 16, circumstances beyond his control left him homeless and living out of his car.
  • Determined to overcome the situation, he developed a five-year plan, committed to doing the work and turned that vision into a reality.
  • Express boasts more than 860 franchise locations in five countries across the globe, garnering $4.1 billion in sales and employing 492,000 associates in 2023.
  • If you would like to arrange for an interview to discuss this topic, please contact [email protected] , Director of Corporate Communications & PR.

Visit International Lithium Corp. at PDAC 2024, Booth #2350

Retrieved on: 
星期三, 二月 28, 2024

Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - Come visit International Lithium Corp. (TSXV: ILC) (OTCQB: ILHMF) (FSE: IAH) (the "Company" or "ILC") at Booth #2350 at the Prospectors & Developers Association of Canada's (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - Come visit International Lithium Corp. (TSXV: ILC) (OTCQB: ILHMF) (FSE: IAH) (the "Company" or "ILC") at Booth #2350 at the Prospectors & Developers Association of Canada's (PDAC) Convention at the Metro Toronto Convention Centre (MTCC) from Sunday, March 3 to Wednesday, March 6, 2024.
  • John Wisbey, Chairman and CEO, will be on hand with Anthony Kovacs, Director and COO, to discuss the recently announced positive PEA* for the Raleigh Lake Lithium project (located along Highway 17 just outside of Ignace, Ontario) and the recently acquired highly prospective Firesteel Copper project** (just down the road near Upsala) - all in Northwestern Ontario.
  • * "The Raleigh Lake Project, NI43-101 Technical Report – PEA," was filed on SEDAR on January 18, 2024 (Company news release dated January 18, 2024).
  • ** Company news release dated February 20, 2024.

International Lithium Files PEA Technical Report for Raleigh Lake Lithium Project - Outlines Highly Favourable After-Tax NPV (discounted at 8%) of CAD$342.9 million and After-Tax IRR of 44.3% p.a.

Retrieved on: 
星期四, 一月 18, 2024

As originally foreshadowed, the very near proximity of Raleigh Lake to existing service infrastructure along the Trans-Canada Highway corridor affords significant logistical and economic advantages to the project.

Key Points: 
  • As originally foreshadowed, the very near proximity of Raleigh Lake to existing service infrastructure along the Trans-Canada Highway corridor affords significant logistical and economic advantages to the project.
  • The Company continues to investigate the potential value associated with the extraction of rubidium from the microcline zone within the spodumene deposit.
  • Economics (discounted at 8% p.a., CAD$)
    Pre-tax Cashflow = CAD$709.4 million, NPV = CAD$385.1 million, IRR = 46.5% p.a.
  • The SGS lab tests obtained 22.9 weight percentages of 6% Lithium Concentrate and estimated 81% lithium recovery
    A copy of The Report, "The Raleigh Lake Project, NI43-101 Technical Report - PEA," was filed on SEDAR on January 18, 2024.